Study Summary
This trial will test if loneliness and social isolation are linked to how someone perceives and is motivated by social interactions. The findings could help provide new targets for treatments to improve quality of life for those with serious mental illnesses.
- Schizophrenia
- Psychosis
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
4 Primary · 0 Secondary · Reporting Duration: 6 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
0 Treatment Group
120 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 55 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is enrollment in this experiment currently available to participants?
"According to the clinicaltrials.gov database, this study is actively enrolling participants - it was initially posted on July 13th 2022 and its latest update occurred August 22nd of that year." - Anonymous Online Contributor
Is the age restriction for this trial above or below 40 years old?
"To be eligible for this research, the age range is 18-55. Those younger than 18 or older than 65 may have more luck finding a suitable trial - 134 and 362 trials respectively cater to these age groups." - Anonymous Online Contributor
Is it feasible to join this clinical investigation?
"This research is looking for 120 participants between 18 and 55 years old, diagnosed with schizophrenia who have experienced a psychotic or affective disorder." - Anonymous Online Contributor
What is the overall participant capacity of this experiment?
"Affirmative. According to information posted on clinicaltrials.gov, recruitment for this trial is currently active and began on July 13th 2022. The last update was published August 22nd 2022 with a need for 120 participants at 1 site." - Anonymous Online Contributor